| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393644A1 Hepatitis virus sentinel virus i (svi) |
| 06/14/2001 | CA2393641A1 Products comprising a support whereon are fixed nucleic acids and their use as dna chip |
| 06/14/2001 | CA2393589A1 Compositions and methods for detecting stress-inducible proteins |
| 06/14/2001 | CA2393584A1 Acyl glucosaminyl inositol amidase family and methods of use |
| 06/14/2001 | CA2393562A1 Detection of transmembrane potentials by optical methods |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393447A1 Novel human membrane proteins and polynucleotides encoding the same |
| 06/14/2001 | CA2393433A1 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation |
| 06/14/2001 | CA2393339A1 Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositions |
| 06/14/2001 | CA2393332A1 Novel human kinase proteins and polynucleotides encoding the same |
| 06/14/2001 | CA2393257A1 A process for converting storage reserves of dicot seeds into compositions comprising one or more gene products |
| 06/14/2001 | CA2393071A1 Long-term cell culture compositions and genetically modified animals derived therefrom |
| 06/14/2001 | CA2393045A1 Mutant er.alpha. and test systems for transactivation |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392764A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
| 06/14/2001 | CA2392753A1 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 06/14/2001 | CA2392742A1 T1 receptor-like ligand ii and uses thereof |
| 06/14/2001 | CA2392740A1 Il-6 like polynucleotides, polypeptides, and antibodies |
| 06/14/2001 | CA2392299A1 Methods for expression of genes in primates |
| 06/14/2001 | CA2391944A1 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 06/14/2001 | CA2390680A1 Rice peroxidases with various characteristics |
| 06/14/2001 | CA2390676A1 Method of testing remedy or preventive for hyperlipemia |
| 06/14/2001 | CA2390354A1 Device for extraction of nucleic acids |
| 06/14/2001 | CA2390093A1 Extracellular matrix and cell adhesion molecules |
| 06/14/2001 | CA2389789A1 Genes involved in cyclododecanone degradation pathway |
| 06/14/2001 | CA2389268A1 Normalization controls and duplex probes for quantitative hybridization reactions |
| 06/14/2001 | CA2388010A1 Rad3 orthologue-1 and uses thereof |
| 06/14/2001 | CA2383001A1 Methods for introducing genes into mammalian subjects |
| 06/14/2001 | CA2382165A1 Full-length human cdnas encoding potentially secreted proteins |
| 06/14/2001 | CA2362685A1 Use of recombinant parainfluenza viruses (pivs) as vectors to protect against infection and disease caused by piv and other human pathogens |
| 06/14/2001 | CA2362649A1 Antibodies binding to human trypsin-like protease and methods for utilizing the same |
| 06/14/2001 | CA2362647A1 Screening method using mice with disrupted neuropilin-1 gene function |
| 06/13/2001 | EP1106702A1 High-throughput screening of compounds using electrospray ionization mass spectrometry (ESI-MS) |
| 06/13/2001 | EP1106697A1 Mass secretion/expression system of true mk family protein |
| 06/13/2001 | EP1106696A1 Protein-deamidating enzyme, microorganism producing the same, gene encoding the same, production process therefor, and use thereof |
| 06/13/2001 | EP1106695A2 Process for the fermentative production of L-amino acids employing coryneform bacteria in which the glyA gene activity has been decreased |
| 06/13/2001 | EP1106694A1 Nucleotide sequences coding for the glk gene |
| 06/13/2001 | EP1106693A1 Nucleotide sequence encoding the zwa2 protein |
| 06/13/2001 | EP1106692A1 Rna virus vector having contact infiltration capability |
| 06/13/2001 | EP1106691A1 Apoptin-associating protein |
| 06/13/2001 | EP1106690A2 Polynucleotide encoding autoantigens associated with endometriosis |
| 06/13/2001 | EP1106689A2 Nucleic acids encoding acetylcholine beta subunits from insects |
| 06/13/2001 | EP1106688A1 Genes for detecting bacteria and detection method by using the same |
| 06/13/2001 | EP1106687A1 Method for isolating satellite sequence |
| 06/13/2001 | EP1106686A1 Artiodactyl epimorphine |
| 06/13/2001 | EP1106685A1 Apparatus for extracting and processing gene motif, method for extracting and processing gene motif and recording medium carrying gene motif extraction/processing program |
| 06/13/2001 | EP1106684A1 Polynucleotide sequences from Corynebacterium glutamicum coding for succinate dehydrogenase subunits (sdhA, sdhB, sdhC) |
| 06/13/2001 | EP1106622A2 New nucleotide sequences coding for the pfKA gene |
| 06/13/2001 | EP1106185A1 Method of administering adenovirus |
| 06/13/2001 | EP1106183A2 Antibodies to erbB2 and their therapeutic uses |
| 06/13/2001 | EP1106061A1 Method for modifying chromosomes |
| 06/13/2001 | EP1106060A1 Model animal with visualized nerve network |
| 06/13/2001 | EP1105738A1 Assays, methods and means for modulating nuclear localisation |
| 06/13/2001 | EP1105734A2 Homer interacting proteins |
| 06/13/2001 | EP1105540A1 Methods of screening nucleic acids for nucleotide variations |
| 06/13/2001 | EP1105539A2 Assays using crosslinkable immobilized nucleic acids |
| 06/13/2001 | EP1105538A2 HUMAN STEAROYL-CoA DESATURASE-RELATED COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS |
| 06/13/2001 | EP1105537A1 Method for determining polynucleotide sequence variations |
| 06/13/2001 | EP1105536A1 Fluorescence polarization in nucleic acid analysis |
| 06/13/2001 | EP1105534A1 $i(CYP3A4) NFSE VARIANT AND METHODS OF USE THEREFOR |
| 06/13/2001 | EP1105533A1 Vessel for blood sampling |
| 06/13/2001 | EP1105532A1 Compositons, kits, and methods for hydrodynamic stress-related regulation of gene expression |
| 06/13/2001 | EP1105527A1 Method of identifying gene transcription patterns |
| 06/13/2001 | EP1105526A1 Hepg2 cells stably transfected with hcv |
| 06/13/2001 | EP1105525A1 A process for preparing peptide nucleic acid probe using polymeric photoacid generator |
| 06/13/2001 | EP1105522A1 Enzyme activity screen with direct substrate reloading |
| 06/13/2001 | EP1105521A1 Enzyme activity screen with substrate replacement |
| 06/13/2001 | EP1105518A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 06/13/2001 | EP1105516A1 Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation |
| 06/13/2001 | EP1105514A1 Polyhydroxyalkanoate production from polyols |
| 06/13/2001 | EP1105513A2 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 06/13/2001 | EP1105512A1 Intracellular delivery vehicles |
| 06/13/2001 | EP1105511A1 Transgenic plants and plant cells comprising a reduced expression of invertase inhibitors |
| 06/13/2001 | EP1105510A2 Dna shuffling to produce herbicide selective crops |
| 06/13/2001 | EP1105509A1 Maize rad6 genes and uses thereof |
| 06/13/2001 | EP1105508A1 Method for purifying proteins and biomolecule or protein complexes |
| 06/13/2001 | EP1105507A1 Overexpression of desired proteins in eukaryotic cells mediated by cyclin d1 overexpression |
| 06/13/2001 | EP1105506A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 06/13/2001 | EP1105505A2 Compound and method for the prevention and/or the treatment of allergy |
| 06/13/2001 | EP1105504A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
| 06/13/2001 | EP1105503A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1) |
| 06/13/2001 | EP1105502A2 Maize cellulose synthases and uses thereof |
| 06/13/2001 | EP1105501A2 Tpl-2/cot kinase and methods of use |
| 06/13/2001 | EP1105500A2 Selection method |
| 06/13/2001 | EP1105499A1 Transgenic microbial polyhydroxyalkanoate producers |
| 06/13/2001 | EP1105498A1 Hiv vaccine |
| 06/13/2001 | EP1105497A1 Cold-adapted equine influenza viruses |
| 06/13/2001 | EP1105496A1 Modified hcv peptide vaccines |
| 06/13/2001 | EP1105495A2 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 06/13/2001 | EP1105494A2 Drug targets in candida albicans |
| 06/13/2001 | EP1105493A1 Basb024 outer membrane protein of neisseria meningitidis |
| 06/13/2001 | EP1105492A1 Cloning of basb023 antigen from moraxella catarrhalis |
| 06/13/2001 | EP1105491A1 Expression of bacterial signal molecules in plants |
| 06/13/2001 | EP1105490A1 Nucleic acid molecules encoding inclusion membrane protein c of chlamydia |
| 06/13/2001 | EP1105489A1 Nucleic acid molecules encoding pomp91a protein of chlamydia |
| 06/13/2001 | EP1105488A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 06/13/2001 | EP1105487A1 Recombinant multivalent malarial vaccine against plasmodium falciparum |
| 06/13/2001 | EP1105486A2 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
| 06/13/2001 | EP1105485A1 Human il-1 epsilon dna and polypeptides |